PIA
EDIT icon

Piedmont Investment Advisors’s Editas Medicine EDIT Stock Holding History

Piedmont Investment Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-793
Closed -$28K – 1396
2018
Q2 		$28K Buy
+793
New +$28.1K ﹤0.01% 1477

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Piedmont Investment Advisors's EDIT Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Editas Medicine (EDIT) in Q3 2018, closing a stake of 793 shares — an estimated $28K sold.

Piedmont Investment Advisors first reported a position in EDIT in Q2 2018 and held it in 1 quarter. The position peaked at $28K in Q2 2018. 199 funds tracked by Wall St. Rank hold EDIT as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Editas Medicine position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 793 Editas Medicine shares in Q3 2018, an estimated $28K.
  • Piedmont Investment Advisors first reported a position in Editas Medicine in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Editas Medicine position peaked at $28K in Q2 2018.
  • 199 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.